M. E. Harper

5.2k total citations · 1 hit paper
66 papers, 4.2k citations indexed

About

M. E. Harper is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, M. E. Harper has authored 66 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 26 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Molecular Biology. Recurrent topics in M. E. Harper's work include Prostate Cancer Treatment and Research (24 papers), Hormonal and reproductive studies (23 papers) and Prostate Cancer Diagnosis and Treatment (13 papers). M. E. Harper is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Hormonal and reproductive studies (23 papers) and Prostate Cancer Diagnosis and Treatment (13 papers). M. E. Harper collaborates with scholars based in United Kingdom, United States and Netherlands. M. E. Harper's co-authors include Julia M.W. Gee, Robert I. Nicholson, K. Griffiths, Denise Barrow, W.B. Peeling, Iain R. Hutcheson, Janice M. Knowlden, Lindy Goddard, Helen E. Jones and Alan E. Wakeling and has published in prestigious journals such as Clinical Cancer Research, Endocrinology and Annals of the New York Academy of Sciences.

In The Last Decade

M. E. Harper

65 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EGFR and cancer prognosis

2001 1.7k citations Robert I. Nicholson, Julia M.W. Gee et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. E. Harper United Kingdom	28	1.9k	1.7k	1.6k	707	668	66	4.2k
Ming‐Fong Lin United States	37	938 0.5×	2.5k 1.5×	1.6k 1.0×	567 0.8×	349 0.5×	100	4.1k
Susan S. Leong United States	16	627 0.3×	1.4k 0.8×	1.1k 0.7×	469 0.7×	392 0.6×	26	2.9k
Nora M. Navone United States	42	1.8k 0.9×	2.8k 1.6×	2.3k 1.5×	578 0.8×	382 0.6×	136	5.4k
Marja T. Nevalainen United States	37	1.7k 0.9×	1.8k 1.0×	1.0k 0.6×	728 1.0×	648 1.0×	77	3.7k
Robert A. Sikes United States	31	956 0.5×	1.6k 0.9×	1.3k 0.8×	385 0.5×	299 0.4×	71	3.3k
Junichi Kurebayashi Japan	37	1.9k 1.0×	1.8k 1.0×	425 0.3×	734 1.0×	497 0.7×	157	3.8k
Wytske M. van Weerden Netherlands	44	1.4k 0.7×	2.0k 1.2×	2.7k 1.7×	613 0.9×	607 0.9×	137	5.2k
Ricardo M. Attar United States	30	877 0.5×	1.7k 1.0×	827 0.5×	485 0.7×	864 1.3×	72	3.2k
Philip A. Watson United States	17	901 0.5×	1.8k 1.1×	3.1k 1.9×	760 1.1×	805 1.2×	25	4.3k
Stefano Pepe Italy	45	2.5k 1.3×	2.6k 1.5×	1.1k 0.7×	366 0.5×	182 0.3×	130	5.3k

Countries citing papers authored by M. E. Harper

Since Specialization

Citations

This map shows the geographic impact of M. E. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Harper more than expected).

Fields of papers citing papers by M. E. Harper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. E. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Harper. The network helps show where M. E. Harper may publish in the future.

Co-authorship network of co-authors of M. E. Harper

This figure shows the co-authorship network connecting the top 25 collaborators of M. E. Harper. A scholar is included among the top collaborators of M. E. Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. E. Harper. M. E. Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicholson, R.I., Iain R. Hutcheson, D. Britton, et al.. (2005). Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies. The Journal of Steroid Biochemistry and Molecular Biology. 93(2-5). 257–262. 47 indexed citations

Rushmere, Neil K., Janice M. Knowlden, Julia M.W. Gee, et al.. (2004). Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer. International Journal of Cancer. 108(6). 930–936. 36 indexed citations

Knowlden, Janice M., Iain R. Hutcheson, Helen E. Jones, et al.. (2003). Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells. Endocrinology. 144(3). 1032–1044. 432 indexed citations

Harper, M. E., Lindy Goddard, Jean W. Assender, et al.. (2002). Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor. The Prostate. 52(1). 59–68. 17 indexed citations

Glynne-Jones, E, M. E. Harper, Liam T. Seery, et al.. (2001). TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. International Journal of Cancer. 94(2). 178–184. 50 indexed citations

Jones, Helen, Denise Barrow, Carol M. Dutkowski, et al.. (2001). Effect of an EGF‐R selective tyrosine kinase inhibitor and an anti‐androgen on LNCaP cells: Identification of divergent growth regulatory pathways. The Prostate. 49(1). 38–47. 14 indexed citations

Nicholson, R.I., Iain R. Hutcheson, M. E. Harper, et al.. (2001). Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer.. Endocrine Related Cancer. 8(3). 175–182. 131 indexed citations

Harper, M. E., et al.. (1998). Expression of androgen receptor and growth factors in premalignant lesions of the prostate. The Journal of Pathology. 186(2). 169–177. 50 indexed citations

Glynne-Jones, E, Lindy Goddard, & M. E. Harper. (1996). Comparative analysis of mrna and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue. Human Pathology. 27(7). 688–694. 58 indexed citations

10.

Evans, B. A. J., et al.. (1996). Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis. The Prostate. 28(3). 162–171. 65 indexed citations

11.

Harper, M. E., Lindy Goddard, E Glynne-Jones, W.B. Peeling, & K. Griffiths. (1995). Epidermal growth factor receptor expression by Northern analysis and immunohistochemistry in benign and malignant prostatic tumours. European Journal of Cancer. 31(9). 1492–1497. 18 indexed citations

12.

Harper, M. E., Lindy Goddard, E Glynne-Jones, et al.. (1993). An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors. The Prostate. 23(1). 9–23. 61 indexed citations

13.

Harper, M. E., E Glynne-Jones, Lindy Goddard, et al.. (1992). Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters. The Prostate. 20(3). 243–253. 63 indexed citations

14.

Harper, M. E., et al.. (1992). Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures. The Prostate. 20(2). 133–149. 28 indexed citations

15.

Harper, M. E., Lindy Goddard, Douglas W. Wilson, et al.. (1992). Pathological and clinical associations of Ki‐67 defined growth fractions in human prostatic carcinoma. The Prostate. 21(1). 75–84. 48 indexed citations

16.

Griffiths, K., et al.. (1991). Steroid Hormones and the Pathogenesis ofBenign Prostatic Hyperplasia. European Urology. 20(1). 68–77. 40 indexed citations

17.

Harper, M. E., Douglas W. Wilson, Hanne M. Jensen, C. G. PIERREPOINT, & K. Griffiths. (1987). Steroid hormone concentrations in relation to patient prognosis and prostate tumour grade. Journal of Steroid Biochemistry. 27(1-3). 521–524. 13 indexed citations

18.

Sibley, Paul, M. E. Harper, W.B. Peeling, & K. Griffiths. (1984). Growth hormone and prostatic tumours: localization using a monoclonal human growth hormone antibody. Journal of Endocrinology. 103(3). 311–315. 11 indexed citations

19.

Battersby, S., et al.. (1983). The Distribution of Zinc in the Prostate of Rhesus and Cynomolgus Monkeys Determined by Electron Microscopy and X-Ray Microanalysis. The Journal of Urology. 129(3). 653–659. 2 indexed citations

20.

Harper, M. E., W.B. Peeling, Brian G. Brownsey, et al.. (1976). PLASMA STEROID AND PROTEIN HORMONE CONCENTRATIONS IN PATIENTS WITH PROSTATIC CARCINOMA, BEFORE AND DURING OESTROGEN THERAPY. European Journal of Endocrinology. 81(2). 409–426. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact